CG Oncology IncNASDAQ:CGON
- LAST PRICE36.7800
- TODAY'S CHANGE (%)0.8700 (2.4227%)
- Bid / Lots36.1300/ 2
- Ask / Lots37.9800/ 1
- Open / Previous Close35.8000 / 35.9100
- Day Range
- 52 Week Range
- Volume344,749
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CGON |
|---|---|---|
| 09:32 ET | 1466 | 35.825 |
| 09:33 ET | 100 | 35.905 |
| 09:35 ET | 100 | 35.62 |
| 09:39 ET | 100 | 35.59 |
| 09:42 ET | 1117 | 35.31 |
| 09:44 ET | 100 | 35.41 |
| 09:48 ET | 300 | 35.49 |
| 09:50 ET | 981 | 35.69 |
| 09:51 ET | 2501 | 35.58 |
| 09:53 ET | 500 | 35.525 |
| 09:55 ET | 529 | 35.54 |
| 09:57 ET | 545 | 35.28 |
| 10:00 ET | 560 | 35.555 |
| 10:02 ET | 200 | 35.58 |
| 10:04 ET | 100 | 35.55 |
| 10:06 ET | 200 | 35.67 |
| 10:09 ET | 400 | 35.605 |
| 10:11 ET | 1834 | 35.87 |
| 10:13 ET | 3133 | 35.955 |
| 10:15 ET | 1700 | 36.02 |
| 10:18 ET | 700 | 36.195 |
| 10:20 ET | 202 | 36.275 |
| 10:22 ET | 400 | 36.29 |
| 10:24 ET | 2312 | 36.41 |
| 10:26 ET | 2723 | 36.52 |
| 10:27 ET | 2300 | 36.42 |
| 10:29 ET | 859 | 36.475 |
| 10:31 ET | 1002 | 36.485 |
| 10:33 ET | 5477 | 36.48 |
| 10:36 ET | 1300 | 36.15 |
| 10:38 ET | 500 | 36.28 |
| 10:40 ET | 100 | 36.315 |
| 10:42 ET | 1060 | 36.3 |
| 10:45 ET | 200 | 36.16 |
| 10:47 ET | 401 | 36.26 |
| 10:49 ET | 2335 | 36.445 |
| 10:51 ET | 300 | 36.595 |
| 10:54 ET | 300 | 36.48 |
| 10:56 ET | 700 | 36.49 |
| 10:58 ET | 618 | 36.67 |
| 11:00 ET | 300 | 36.65 |
| 11:02 ET | 400 | 36.68 |
| 11:05 ET | 2700 | 36.69 |
| 11:07 ET | 500 | 36.66 |
| 11:09 ET | 300 | 36.715 |
| 11:12 ET | 387 | 36.76 |
| 11:14 ET | 1043 | 36.63 |
| 11:18 ET | 300 | 36.68 |
| 11:20 ET | 1600 | 36.605 |
| 11:21 ET | 800 | 36.46 |
| 11:23 ET | 300 | 36.425 |
| 11:25 ET | 598 | 36.12 |
| 11:27 ET | 1600 | 36.24 |
| 11:30 ET | 546 | 36.255 |
| 11:32 ET | 300 | 36.295 |
| 11:34 ET | 100 | 36.325 |
| 11:36 ET | 100 | 36.37 |
| 11:38 ET | 100 | 36.27 |
| 11:39 ET | 1000 | 36.27 |
| 11:43 ET | 432 | 36.27 |
| 11:45 ET | 679 | 36.255 |
| 11:48 ET | 500 | 36.29 |
| 11:52 ET | 600 | 36.03 |
| 11:54 ET | 200 | 36.04 |
| 11:56 ET | 1505 | 36.17 |
| 11:59 ET | 300 | 36.125 |
| 12:01 ET | 600 | 36.13 |
| 12:06 ET | 500 | 36.2199 |
| 12:10 ET | 2500 | 36.2 |
| 12:12 ET | 2100 | 36.31 |
| 12:14 ET | 200 | 36.37 |
| 12:15 ET | 842 | 36.39 |
| 12:17 ET | 1600 | 36.34 |
| 12:19 ET | 700 | 36.39 |
| 12:21 ET | 300 | 36.365 |
| 12:24 ET | 200 | 36.365 |
| 12:26 ET | 200 | 36.38 |
| 12:30 ET | 800 | 36.42 |
| 12:32 ET | 1000 | 36.475 |
| 12:33 ET | 300 | 36.475 |
| 12:35 ET | 2100 | 36.5 |
| 12:37 ET | 400 | 36.48 |
| 12:39 ET | 300 | 36.475 |
| 12:42 ET | 4010 | 36.57 |
| 12:44 ET | 100 | 36.585 |
| 12:46 ET | 100 | 36.6 |
| 12:48 ET | 300 | 36.61 |
| 12:50 ET | 1100 | 36.59 |
| 12:51 ET | 401 | 36.64 |
| 12:53 ET | 100 | 36.63 |
| 12:55 ET | 400 | 36.7 |
| 12:57 ET | 309 | 36.67 |
| 01:00 ET | 200 | 36.67 |
| 01:02 ET | 300 | 36.7 |
| 01:04 ET | 1465 | 36.63 |
| 01:06 ET | 309 | 36.6 |
| 01:08 ET | 1073 | 36.42 |
| 01:09 ET | 200 | 36.48 |
| 01:11 ET | 100 | 36.505 |
| 01:13 ET | 100 | 36.51 |
| 01:15 ET | 100 | 36.52 |
| 01:18 ET | 100 | 36.545 |
| 01:20 ET | 200 | 36.545 |
| 01:22 ET | 300 | 36.58 |
| 01:24 ET | 100 | 36.6 |
| 01:26 ET | 300 | 36.6 |
| 01:29 ET | 500 | 36.61 |
| 01:31 ET | 1115 | 36.61 |
| 01:38 ET | 100 | 36.61 |
| 01:40 ET | 200 | 36.61 |
| 01:44 ET | 300 | 36.61 |
| 01:49 ET | 300 | 36.61 |
| 01:54 ET | 700 | 36.67 |
| 01:56 ET | 200 | 36.75 |
| 01:58 ET | 1102 | 36.76 |
| 02:00 ET | 200 | 36.685 |
| 02:03 ET | 1535 | 36.825 |
| 02:05 ET | 200 | 36.83 |
| 02:07 ET | 100 | 36.9 |
| 02:09 ET | 10829 | 36.965 |
| 02:12 ET | 4097 | 36.76 |
| 02:21 ET | 300 | 36.865 |
| 02:23 ET | 300 | 36.93 |
| 02:25 ET | 100 | 36.925 |
| 02:27 ET | 100 | 36.97 |
| 02:30 ET | 1016 | 36.72 |
| 02:34 ET | 800 | 36.745 |
| 02:36 ET | 300 | 36.745 |
| 02:38 ET | 300 | 36.74 |
| 02:39 ET | 381 | 36.71 |
| 02:41 ET | 2556 | 36.75 |
| 02:45 ET | 401 | 36.71 |
| 02:48 ET | 200 | 36.71 |
| 02:50 ET | 400 | 36.83 |
| 02:52 ET | 100 | 36.75 |
| 02:54 ET | 200 | 36.755 |
| 02:56 ET | 200 | 36.8 |
| 02:57 ET | 500 | 36.83 |
| 02:59 ET | 1200 | 36.845 |
| 03:01 ET | 1700 | 36.84 |
| 03:03 ET | 100 | 36.89 |
| 03:06 ET | 1700 | 36.92 |
| 03:08 ET | 200 | 36.91 |
| 03:10 ET | 100 | 36.97 |
| 03:12 ET | 1446 | 36.92 |
| 03:14 ET | 100 | 36.94 |
| 03:15 ET | 600 | 36.95 |
| 03:17 ET | 1389 | 36.945 |
| 03:19 ET | 1800 | 36.905 |
| 03:21 ET | 8302 | 37.02 |
| 03:24 ET | 2401 | 37.02 |
| 03:28 ET | 300 | 37.015 |
| 03:30 ET | 100 | 37.08 |
| 03:32 ET | 1060 | 37.075 |
| 03:33 ET | 300 | 37.03 |
| 03:35 ET | 1200 | 36.95 |
| 03:37 ET | 899 | 36.9 |
| 03:39 ET | 500 | 36.87 |
| 03:42 ET | 300 | 36.79 |
| 03:44 ET | 1400 | 36.915 |
| 03:46 ET | 1900 | 36.87 |
| 03:48 ET | 1460 | 36.86 |
| 03:50 ET | 1900 | 36.85 |
| 03:51 ET | 600 | 36.84 |
| 03:53 ET | 2607 | 36.86 |
| 03:55 ET | 3428 | 36.94 |
| 03:57 ET | 8195 | 36.81 |
| 04:00 ET | 53660 | 36.78 |
Oct 24, 2024
DJ CG Oncology Initiated at Buy by UBS, from 7:35AM ET on Thursday Oct 24, 2024 by Dow Jones
7:35AM ET on Thursday Oct 24, 2024 by Dow Jones
Oct 8, 2024
DJ CG Oncology Is Maintained at Buy by B of A Securities, from 11:51AM ET on Tuesday Oct 08, 2024 by Dow Jones
11:51AM ET on Tuesday Oct 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CG Oncology Inc | 2.4B | -31.5x | --- |
Vera Therapeutics Inc | 2.4B | -20.5x | --- |
Structure Therapeutics Inc | 2.4B | -17.8x | --- |
Geron Corp | 2.5B | -11.8x | --- |
Longboard Pharmaceuticals Inc | 2.3B | -27.5x | --- |
IDEAYA Biosciences Inc | 2.4B | -13.8x | --- |
Company Information
CG Oncology, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The Company’s product candidate, cretostimogene is initially in clinical development for the treatment of patients with non-muscle invasive bladder cancer (NMIBC). Its lead candidate, BOND-003 is a targeted oncolytic intravesically delivered immunotherapy agent that is in Phase II for the treatment of Bacillus Calmette Guerin (BCG) unresponsive and intermediate risk NMIBC disease. Its other product candidate CORE-001 is a Phase II single-arm, open-label clinical trial of cretostimogene administered with BCG-unresponsive NMIBC. Its portfolio also includes PIVOT-006, a Phase III trial to assess the safety and efficacy of adjuvant cretostimogene when administered as monotherapy to patients with intermediate-risk NMIBC following transurethral resection of the bladder tumor (TURBT).
Contact Information
- Headquarters
- 400 Spectrum Center Drive, Suite 2040IRVINE, CA, United States 92618
- Phone
- 949-288-6298
- Fax
- 302-531-3150
Executives
- Chairman of the Board, Chief Executive Officer
- Arthur Kuan
- President, Chief Operating Officer
- Ambaw Bellete
- Chief Financial Officer
- Stephen Dipalma
- Chief Medical Officer
- Vijay Kasturi
- Lead Independent Director
- Leonard Post
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
|---|---|
Revenue (TTM) | $650.0K |
Shares Outstanding | 67.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.17 |
Book Value | $2.91 |
P/E Ratio | -31.5x |
Price/Sales (TTM) | 3,705.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,572.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
